ArticleGenes & diseases2026

Multi-omics Mendelian randomization to identify novel immune therapeutic targets in benign prostatic hyperplasia.

Zhenpeng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.